JetBlue Airways Corporation : Close to a key point
Entry price | Target | Stop-loss | Potential |
---|
US$20 |
US$0 |
US$18.8 |
-100% |
---|
JetBlue Airways Corporation comes back upon contact with important technical level that might give impetus to a rebound.
From a fundamental viewpoint, the company shows positive information with an estimated P/E ratio of 8x for the current year. Furthermore, the EV/Sales ratio is 1.08x and that confirms the low valuation. Revenues and operating margin growth rates add relevance to this investment.
The area of the USD 19.35 support should enable the stock to have a new bullish trend. The long term support in this area confirms its relevance. Technically, above these levels, 4-traders analysts are optimistic and count on a return toward the short and mid-term resistances.
Ideally, investors will take a long position nearby the USD 19.34 support currently tested, in order to benefit from a technical rebound. The USD 22 is the first goal and then the USD 23.4 will be reached.
This strategy should be covered by a stop loss placed under the USD 19.34 support because a breakdown of this level would invalidate it.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.